Drug Database
Back to search

Belgium· BE-AMP-SAM239224-00

Coruno 16 mg

A molsidomine product containing molsidomine, registered in Belgium by Therabel Pharma. The same ATC class is registered in 8 of our 19 countries.

ATC C01DX12

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCoruno 16 mgATCC01DX12REGISTER NO.BE-AMP-SAM239224-00PACKS LISTED4CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about molsidomineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Molsidomine is registered in 8 of 19 countries.

Countries holding a registration under ATC C01DX12 (molsidomine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search molsidomine products by name

Molsidomine · ATC C01DX12

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Germany
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of molsidomine costs, country by country.

Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.33 in France to $0.63 in Switzerland — a ×1.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Molsidomine · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.63
  • FR France$0.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Molsidomine
Manufacturer
Therabel Pharma
Country
Belgium (BE)
ATC code
C01DX12
ATC class
Molsidomine
Defined daily dose
8 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

2 priced
  • be_apb
    1745389
    EUR 28.08
  • be_apb
    2087641
    EUR 35.19
  • be_apb
    0771311
  • be_apb
    2087633

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for molsidomine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check molsidomine against other medicinesHow interaction checks work

Molsidomine · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Molsidomine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All molsidomine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Molsidolat
  • Bulgaria · Молсидомин Wzf, Сиднофарм
  • Czechia · Corvaton Forte
  • Germany · Corvaton, Corvaton Forte
  • Spain · Molsidain
  • France · Corvasal, Molsidomine Arrow
  • Hungary · Corvaton, Corvaton Forte
  • Lithuania · Molsidominum Pph
  • Luxembourg · Coruno, Corvaton
  • Poland · Molsidomina Wzf
  • Slovakia · Corvaton, Corvaton Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/901b01ba-e05a-4b78-ad8b-dc2d0fb10253
GET /v1/drugs/901b01ba-e05a-4b78-ad8b-dc2d0fb10253?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Coruno 16 mg",
  "name_fr": "Coruno 16 mg",
  "name_nl": "Coruno 16 mg",
  "amp_code": "SAM239224-00",
  "strengths": [
    "16.0000",
    "5.0000",
    "71.7750"
  ],
  "pack_count": 4,
  "substances": [
    "Molsidomine",
    "Mannitol",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Molsidomine",
  "authorisation_numbers": [
    "BE239224"
  ]
}
API referenceMCP serverPlans

See everything about molsidomine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console